| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.443 | 0.001 | 0.443 | DNA polymerase III inhibitor | 0.38 0.001 DBMET03496 0.38 0.001 DBMET03497 0.241 0.002 DBMET03498 | ||
| 0.338 | 0.001 | 0.338 | DNA polymerase III polC-type inhibitor | 0.291 0.001 DBMET03496 0.294 0.001 DBMET03497 0.076 0.002 DBMET03498 | ||
| 0.388 | 0.065 | 0.388 | Toll-Like receptor 7 agonist | 0.353 0.08 DBMET03496 0.321 0.098 DBMET03497 0.294 0.114 DBMET03498 | ||
| 0.381 | 0.068 | 0.381 | Toll-Like receptor agonist | 0.345 0.084 DBMET03496 0.32 0.099 DBMET03497 0.307 0.107 DBMET03498 | ||
| 0.366 | 0.054 | 0.53 | Immunomodulator | 0.314 0.075 DBMET03496 0.43 0.036 DBMET03497 0.53 0.019 DBMET03498 | DBMET03498 | |
| 0.264 | 0.008 | 0.264 | Aminoacyl-tRNA synthetase inhibitor | 0.242 0.009 DBMET03496 0.23 0.009 DBMET03497 0.165 0.015 DBMET03498 | ||
| 0.378 | 0.125 | 0.402 | DNA directed DNA polymerase inhibitor | 0.402 0.114 DBMET03496 0.334 0.146 DBMET03497 | DBMET03496 | |
| 0.252 | 0.006 | 0.252 | MAP kinase kinase 5 inhibitor | 0.225 0.014 DBMET03496 0.193 0.04 DBMET03497 0.165 0.099 DBMET03498 | ||
| 0.265 | 0.045 | 0.265 | ErbB-1 antagonist | 0.26 0.047 DBMET03496 0.22 0.07 DBMET03497 | ||
| 0.195 | 0.021 | 0.236 | Aurora-C kinase inhibitor | 0.172 0.031 DBMET03496 0.236 0.012 DBMET03497 | DBMET03497 | |
| 0.188 | 0.035 | 0.4 | Cell wall synthesis inhibitor | 0.205 0.028 DBMET03496 0.167 0.05 DBMET03497 0.4 0.006 DBMET03498 | DBMET03498 | |
| 0.159 | 0.009 | 0.264 | Purinergic P2 antagonist | 0.101 0.021 DBMET03496 0.264 0.005 DBMET03497 | DBMET03497 | |
| 0.153 | 0.01 | 0.153 | Phosphatidylinositol 3-kinase delta inhibitor | 0.114 0.017 DBMET03496 0.081 0.025 DBMET03497 | ||
| 0.137 | 0.004 | 0.137 | Purinergic P2X3 antagonist | 0.104 0.004 DBMET03496 0.111 0.004 DBMET03497 0.042 0.015 DBMET03498 | ||
| 0.139 | 0.008 | 0.139 | Phosphatidylinositol 3-kinase beta inhibitor | 0.103 0.012 DBMET03496 0.073 0.019 DBMET03497 | ||
| 0.156 | 0.037 | 0.156 | Cyclin-dependent kinase 5 inhibitor | 0.138 0.047 DBMET03496 | ||
| 0.135 | 0.017 | 0.135 | Cyclin B3 inhibitor | 0.131 0.018 DBMET03496 | ||
| 0.163 | 0.05 | 0.178 | MAP kinase 3 inhibitor | 0.139 0.086 DBMET03496 0.178 0.036 DBMET03497 | DBMET03497 | |
| 0.234 | 0.122 | 0.234 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.219 0.137 DBMET03496 | ||
| 0.117 | 0.007 | 0.177 | Purinergic P2X antagonist | 0.071 0.017 DBMET03496 0.177 0.005 DBMET03497 | DBMET03497 | |
| 0.161 | 0.054 | 0.217 | Cytokine production inhibitor | 0.128 0.081 DBMET03496 0.217 0.031 DBMET03497 | DBMET03497 | |
| 0.109 | 0.018 | 0.109 | Polo-like kinase-2 inhibitor | 0.091 0.034 DBMET03496 0.081 0.043 DBMET03497 | ||
| 0.119 | 0.031 | 0.119 | Polo-like kinase-1 inhibitor | 0.093 0.056 DBMET03496 0.086 0.07 DBMET03497 | ||
| 0.299 | 0.214 | 0.299 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.18 | 0.095 | 0.18 | MAP kinase kinase 2 inhibitor | 0.17 0.103 DBMET03496 0.166 0.107 DBMET03497 | ||
| 0.136 | 0.053 | 0.136 | MAP kinase 12 inhibitor | 0.108 0.087 DBMET03496 | ||
| 0.237 | 0.163 | 0.237 | Calcium channel activator | 0.218 0.188 DBMET03496 | ||
| 0.123 | 0.053 | 0.123 | MAP kinase 13 inhibitor | 0.094 0.092 DBMET03496 | ||
| 0.138 | 0.069 | 0.138 | Nav1.6 sodium channel blocker | |||
| 0.075 | 0.009 | 0.075 | Acetyl-CoA carboxylase inhibitor | 0.055 0.017 DBMET03496 0.044 0.026 DBMET03497 | ||
| 0.094 | 0.034 | 0.094 | HIV-1 reverse transcriptase inhibitor | 0.081 0.042 DBMET03496 | ||
| 0.058 | 0.007 | 0.058 | Complement C5a chemotactic receptor antagonist | 0.035 0.015 DBMET03496 0.031 0.019 DBMET03497 | ||
| 0.07 | 0.019 | 0.07 | Myc inhibitor | 0.061 0.028 DBMET03496 | ||
| 0.263 | 0.218 | 0.263 | MAP kinase 1 inhibitor | |||
| 0.079 | 0.035 | 0.079 | Adenosine A2 receptor antagonist | 0.059 0.049 DBMET03496 | ||
| 0.068 | 0.025 | 0.068 | Protein kinase C epsilon inhibitor | 0.055 0.036 DBMET03496 0.049 0.042 DBMET03497 | ||
| 0.193 | 0.15 | 0.243 | Tyrosine 3 hydroxylase inhibitor | 0.243 0.075 DBMET03496 | DBMET03496 | |
| 0.148 | 0.106 | 0.298 | DNA methyltransferase I inhibitor | 0.191 0.074 DBMET03496 0.298 0.027 DBMET03498 | DBMET03498 | |
| 0.105 | 0.065 | 0.105 | Ferrochelatase inhibitor | |||
| 0.116 | 0.077 | 0.116 | Epidermal growth factor receptor kinase inhibitor | 0.102 0.095 DBMET03496 | ||
| 0.045 | 0.008 | 0.045 | Acetyl-CoA carboxylase 2 inhibitor | 0.024 0.015 DBMET03496 | ||
| 0.07 | 0.033 | 0.07 | Phosphatidylinositol kinase inhibitor | 0.057 0.045 DBMET03496 0.058 0.043 DBMET03497 | ||
| 0.069 | 0.034 | 0.069 | Adenosine A1 receptor antagonist | 0.059 0.04 DBMET03496 | ||
| 0.083 | 0.049 | 0.165 | Cell adhesion molecule inhibitor | 0.071 0.069 DBMET03496 0.165 0.013 DBMET03498 | DBMET03498 | |
| 0.089 | 0.055 | 0.089 | Epidermal growth factor antagonist | 0.076 0.071 DBMET03496 | ||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | 0.061 0.046 DBMET03496 0.062 0.043 DBMET03497 | ||
| 0.076 | 0.042 | 0.076 | Phospholipase D inhibitor | |||
| 0.062 | 0.029 | 0.062 | Cyclin B inhibitor | 0.062 0.029 DBMET03496 | ||
| 0.071 | 0.038 | 0.071 | CDK1/cyclin B inhibitor | 0.057 0.05 DBMET03496 | ||
| 0.118 | 0.086 | 0.137 | Papain-like protease (SARS coronavirus) inhibitor | 0.137 0.048 DBMET03496 | DBMET03496 | |
| 0.149 | 0.118 | 0.306 | DNA methylase inhibitor | 0.187 0.088 DBMET03496 0.306 0.026 DBMET03498 | DBMET03498 | |
| 0.134 | 0.104 | 0.134 | Polo-like kinase-3 inhibitor | |||
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | 0.044 0.036 DBMET03496 0.047 0.027 DBMET03497 | ||
| 0.173 | 0.146 | 0.187 | RNA-directed DNA polymerase inhibitor | 0.187 0.12 DBMET03496 | DBMET03496 | |
| 0.064 | 0.038 | 0.066 | Cyclin B1 inhibitor | 0.066 0.037 DBMET03496 | DBMET03496 | |
| 0.059 | 0.034 | 0.061 | Cyclin B2 inhibitor | 0.061 0.031 DBMET03496 | DBMET03496 | |
| 0.053 | 0.031 | 0.053 | Adenosine A2b receptor antagonist | 0.047 0.037 DBMET03497 | ||
| 0.066 | 0.046 | 0.066 | MAP kinase kinase 10 inhibitor | |||
| 0.091 | 0.072 | 0.217 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 DBMET03496 0.111 0.05 DBMET03497 0.217 0.016 DBMET03498 | DBMET03498 | |
| 0.088 | 0.07 | 0.088 | CDK2/cyclin A inhibitor | |||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.06 | 0.045 | 0.06 | Adenosine A2a receptor antagonist | |||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET03496 0.026 0.018 DBMET03497 | ||
| 0.106 | 0.097 | 0.106 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.121 | 0.113 | 0.131 | MAP3K9 inhibitor | 0.121 0.112 DBMET03496 0.131 0.093 DBMET03497 | DBMET03497 | |
| 0.084 | 0.078 | 0.084 | DNA directed RNA polymerase inhibitor | 0.083 0.08 DBMET03497 | ||
| 0.034 | 0.029 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.103 | 0.098 | 0.16 | Alpha-N-acetylglucosaminidase inhibitor | 0.146 0.057 DBMET03497 0.16 0.049 DBMET03498 | DBMET03498 | |
| 0.032 | 0.028 | 0.032 | CDK6/cyclin D3 inhibitor | |||
| 0.008 | 0.005 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.007 | 0.004 | 0.007 | DNA polymerase III subunit alpha inhibitor | 0.007 0.005 DBMET03497 | ||
| 0.058 | 0.059 | 0.066 | Interferon inducer | 0.066 0.04 DBMET03498 | DBMET03498 | |
| 0.063 | 0.065 | 0.071 | MDM2 inhibitor | 0.071 0.037 DBMET03497 | DBMET03497 | |
| 0.052 | 0.06 | 0.085 | p38 MAP kinase inhibitor | 0.085 0.038 DBMET03497 | DBMET03497 | |
| 0.074 | 0.089 | 0.136 | NADH dehydrogenase inhibitor | 0.08 0.074 DBMET03496 0.081 0.072 DBMET03497 0.136 0.022 DBMET03498 | DBMET03498 | |
| 0.065 | 0.081 | 0.079 | Interferon agonist | 0.079 0.053 DBMET03498 | DBMET03498 | |
| 0.091 | 0.106 | 0.156 | MAP kinase kinase inhibitor | 0.104 0.091 DBMET03496 0.156 0.048 DBMET03497 | DBMET03497 | |
| 0.09 | 0.111 | 0.118 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.118 0.083 DBMET03496 | DBMET03496 | |
| 0.04 | 0.062 | 0.055 | CXC chemokine 1 receptor antagonist | 0.055 0.029 DBMET03496 | DBMET03496 | |
| 0.188 | 0.211 | 0.391 | Interleukin 2 agonist | 0.236 0.135 DBMET03496 0.238 0.133 DBMET03497 0.391 0.03 DBMET03498 | DBMET03498 | |
| 0.101 | 0.125 | 0.188 | DNA repair enzyme inhibitor | 0.188 0.011 DBMET03498 | DBMET03498 | |
| 0.043 | 0.069 | 0.061 | Carbamoyl phosphate synthetase inhibitor | 0.061 0.042 DBMET03497 | DBMET03497 | |
| 0.015 | 0.043 | 0.024 | Uridine phosphorylase inhibitor | 0.024 0.023 DBMET03497 | DBMET03497 | |
| 0.071 | 0.105 | 0.078 | CC chemokine 5 receptor agonist | 0.078 0.074 DBMET03496 | DBMET03496 | |
| 0.045 | 0.083 | 0.067 | DNA gyrase inhibitor | 0.067 0.039 DBMET03498 | DBMET03498 | |
| 0.085 | 0.13 | 0.24 | Cell adhesion inhibitor | 0.24 0.016 DBMET03498 | DBMET03498 | |
| 0.067 | 0.137 | 0.124 | MAP kinase kinase 1 inhibitor | 0.124 0.031 DBMET03497 | DBMET03497 | |
| 0.064 | 0.159 | 0.362 | Amylase inhibitor | 0.122 0.08 DBMET03496 0.362 0.012 DBMET03498 | DBMET03498 | |
| 0.088 | 0.185 | 0.131 | TRKC antagonist | 0.131 0.12 DBMET03497 | DBMET03497 | |
| 0.102 | 0.213 | 0.25 | Interleukin agonist | 0.25 0.079 DBMET03498 | DBMET03498 | |
| 0.049 | 0.169 | 0.099 | Creatine kinase inhibitor | 0.099 0.06 DBMET03496 | DBMET03496 | |
| 0.051 | 0.18 | 0.084 | Triose-phosphate isomerase inhibitor | 0.084 0.069 DBMET03498 | DBMET03498 | |
| 0.068 | 0.213 | 0.124 | Peroxidase inhibitor | 0.124 0.096 DBMET03496 | DBMET03496 | |
| 0.016 | 0.17 | 0.032 | Estrogen-related receptor beta antagonist | 0.032 0.023 DBMET03496 | DBMET03496 | |
| 0.021 | 0.181 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.029 DBMET03498 | DBMET03498 | |
| 0.015 | 0.175 | 0.051 | Mannosidase inhibitor | 0.051 0.024 DBMET03498 | DBMET03498 | |
| 0.018 | 0.185 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.008 DBMET03498 | DBMET03498 | |
| 0.173 | 0.358 | 0.243 | 5 Hydroxytryptamine release inhibitor | 0.243 0.238 DBMET03498 | DBMET03498 | |
| 0.12 | 0.306 | 0.349 | Peptidyltransferase inhibitor | 0.163 0.162 DBMET03496 0.194 0.108 DBMET03497 0.349 0.012 DBMET03498 | DBMET03498 | |
| 0.178 | 0.368 | 0.68 | Antiinflammatory | 0.68 0.035 DBMET03498 | DBMET03498 | |
| 0.112 | 0.302 | 0.343 | Cholesterol antagonist | 0.343 0.067 DBMET03498 | DBMET03498 | |
| 0.128 | 0.34 | 0.598 | Antibacterial | 0.598 0.019 DBMET03498 | DBMET03498 | |
| 0.105 | 0.322 | 0.225 | Angiogenesis inhibitor | 0.225 0.143 DBMET03498 | DBMET03498 | |
| 0.125 | 0.347 | 0.264 | Histamine release inhibitor | 0.264 0.145 DBMET03498 | DBMET03498 | |
| 0.087 | 0.315 | 0.157 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.14 DBMET03498 | DBMET03498 | |
| 0.072 | 0.365 | 0.171 | ATPase inhibitor | 0.171 0.069 DBMET03498 | DBMET03498 | |
| 0.006 | 0.307 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 DBMET03498 | DBMET03498 | |
| 0.05 | 0.351 | 0.367 | Immunostimulant | 0.367 0.059 DBMET03498 | DBMET03498 | |
| 0.09 | 0.397 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.052 DBMET03498 | DBMET03498 | |
| 0.04 | 0.35 | 0.176 | Anticoagulant | 0.176 0.063 DBMET03498 | DBMET03498 | |
| 0.077 | 0.411 | 0.467 | Antithrombotic | 0.467 0.034 DBMET03498 | DBMET03498 | |
| 0.087 | 0.428 | 0.24 | Vasodilator, coronary | 0.24 0.144 DBMET03498 | DBMET03498 | |
| 0.054 | 0.403 | 0.135 | Melanin inhibitor | 0.135 0.106 DBMET03498 | DBMET03498 | |
| 0.05 | 0.438 | 0.27 | Alpha-glucosidase inhibitor | 0.27 0.176 DBMET03498 | DBMET03498 | |
| 0.014 | 0.406 | 0.096 | Expectorant | 0.096 0.073 DBMET03498 | DBMET03498 | |
| 0.054 | 0.451 | 0.208 | DNA synthesis inhibitor | 0.208 0.112 DBMET03498 | DBMET03498 | |
| 0.056 | 0.461 | 0.404 | Immunosuppressant | 0.404 0.061 DBMET03498 | DBMET03498 | |
| 0.021 | 0.463 | 0.119 | AMP-activated protein kinase stimulant | 0.119 0.049 DBMET03498 | DBMET03498 | |
| 0.033 | 0.478 | 0.124 | Cyclooxygenase 3 inhibitor | 0.124 0.073 DBMET03498 | DBMET03498 | |
| 0.014 | 0.463 | 0.056 | Heparanase inhibitor | 0.056 0.029 DBMET03498 | DBMET03498 | |
| 0.033 | 0.514 | 0.104 | Transcription factor NF kappa B stimulant | 0.104 0.035 DBMET03498 | DBMET03498 | |
| 0.022 | 0.52 | 0.052 | Adenine nucleotide translocase inhibitor | 0.052 0.048 DBMET03498 | DBMET03498 | |
| 0.015 | 0.556 | 0.188 | Lipid peroxidase inhibitor | 0.188 0.047 DBMET03498 | DBMET03498 | |
| 0.005 | 0.572 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.015 DBMET03498 | DBMET03498 | |
| 0.014 | 0.583 | 0.097 | ATPase (Vacuolar H+) inhibitor | 0.097 0.044 DBMET03498 | DBMET03498 | |
| 0.023 | 0.602 | 0.139 | Hemostatic | 0.139 0.082 DBMET03498 | DBMET03498 | |
| 0.01 | 0.597 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 DBMET03498 | DBMET03498 | |
| 0.014 | 0.625 | 0.051 | Factor IXa inhibitor | 0.051 0.036 DBMET03498 | DBMET03498 | |
| 0.019 | 0.651 | 0.138 | Interleukin 6 antagonist | 0.138 0.108 DBMET03498 | DBMET03498 | |
| 0.018 | 0.718 | 0.123 | Toll-Like receptor 4 antagonist | 0.123 0.041 DBMET03498 | DBMET03498 | |
| 0.01 | 0.712 | 0.162 | Platelet antagonist | 0.162 0.132 DBMET03498 | DBMET03498 | |
| 0.007 | 0.741 | 0.073 | Protein 50S ribosomal subunit inhibitor | 0.073 0.023 DBMET03498 | DBMET03498 | |
| 0.01 | 0.792 | 0.217 | Tumour necrosis factor alpha release inhibitor | 0.217 0.095 DBMET03498 | DBMET03498 | |
| 0.018 | 0.804 | 0.585 | Cyclophilin D inhibitor | 0.585 0.03 DBMET03498 | DBMET03498 | |
| 0.003 | 0.795 | 0.085 | Antineoplastic antibiotic | 0.085 0.054 DBMET03498 | DBMET03498 | |
| 0.005 | 0.815 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 DBMET03498 | DBMET03498 | |
| 0.025 | 0.854 | 0.144 | NOS3 expression enhancer | 0.144 0.079 DBMET03498 | DBMET03498 | |
| 0.008 | 0.869 | 0.447 | Angiogenesis stimulant | 0.447 0.016 DBMET03498 | DBMET03498 | |
| 0.006 | 0.882 | 0.229 | Nitric oxide antagonist | 0.229 0.058 DBMET03498 | DBMET03498 | |
| 0.008 | 0.911 | 0.331 | Apoptosis agonist | 0.331 0.151 DBMET03498 | DBMET03498 | |
| 0.005 | 0.913 | 0.168 | Thrombolytic | 0.168 0.069 DBMET03498 | DBMET03498 | |
| 0.015 | 0.925 | 0.27 | Apoptosis antagonist | 0.27 0.109 DBMET03498 | DBMET03498 | |
| 0.005 | 0.931 | 0.362 | Antioxidant | 0.362 0.043 DBMET03498 | DBMET03498 | |
| 0.003 | 0.955 | 0.251 | Selectin antagonist | 0.251 0.008 DBMET03498 | DBMET03498 | |
| 0.006 | 0.962 | 0.168 | Platelet adhesion inhibitor | 0.168 0.089 DBMET03498 | DBMET03498 | |
| 0.008 | 0.971 | 0.271 | Hepatoprotectant | 0.271 0.038 DBMET03498 | DBMET03498 | |
| 0.005 | 0.982 | 0.367 | Hypoglycemic | 0.367 0.034 DBMET03498 | DBMET03498 | |
| 0.003 | 0.995 | 0.262 | Free radical scavenger | 0.262 0.064 DBMET03498 | DBMET03498 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |